Cerus reported $52.87M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Atrion ATRI:US 37.85M 5.4M
Cerulean Pharma CERU:US $ 8.4M 1.14M
Cytori Therapeutics CYTX:US $ 5.12M 1.19M
Haemonetics HAE:US $ 230.69M 15.11M
Meridian Bioscience VIVO:US $ 74.45M 638K
Nuvasive NUVA:US $ 277.38M 1.45M
Sientra SIEN:US 37.45M 42K
Terumo 4543:JP Y 166913M 8597M